| P2093 | author name string | Zhe Wang | |
| | Lu Yu | |
| | Zheng Yang | |
| P2860 | cites work | The erg gene: a human gene related to the ets oncogene | Q24299030 |
| | Global cancer statistics, 2012 | Q27860501 |
| | Predicting prostate biopsy outcome using a PCA3-based nomogram in a Polish cohort | Q40091198 |
| | Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol. | Q40093970 |
| | ERG gene rearrangements are common in prostatic small cell carcinomas | Q41628946 |
| | Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells | Q44287808 |
| | Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients | Q44399685 |
| | Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases | Q48592065 |
| | Words of wisdom. Re: PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume. Whitman EJ, Groskopf J, Ali A, et al. J Urol 2008;180:1975-8; discussion 1978-9. | Q52906782 |
| | TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion | Q57693484 |
| | Small Cell (Neuroendocrine) Carcinoma of the Prostate: Etiology, Diagnosis, Prognosis, and Therapeutic Implications—A Retrospective Study of 30 Patients From the Rare Cancer Network | Q58890491 |
| | Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of Prostate-Specific Antigen (PSA) Isoforms for the Detection of Prostate Cancer in Men with a PSA Level of 2–10ng/ml: Systematic Review and Meta-Analysis. Eur Urol 2005;48:386–99 | Q62632500 |
| | Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8?16 | Q62632515 |
| | Disease progression following radical prostatectomy in men with Gleason score 7 tumor | Q74654431 |
| | Urine PCA3 and TMPRSS2:ERG using cancer-specific markers to detect cancer | Q85780783 |
| | Role of transforming growth factor-beta signaling in cancer | Q28145449 |
| | erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation | Q28295357 |
| | Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome | Q33212600 |
| | Delineation of TMPRSS2-ERG splice variants in prostate cancer | Q33357287 |
| | DD3: a new prostate-specific gene, highly overexpressed in prostate cancer | Q33884277 |
| | Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens | Q34148474 |
| | DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer | Q34206957 |
| | PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. | Q34468270 |
| | TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer | Q34508696 |
| | Small cell carcinoma of the prostate: an immunohistochemical study. | Q34530449 |
| | PCA3: a molecular urine assay for predicting prostate biopsy outcome | Q34754205 |
| | Transforming growth factor-β and the hallmarks of cancer | Q34789300 |
| | PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience | Q35074229 |
| | Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis. | Q35208625 |
| | Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer | Q35249281 |
| | Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis | Q36176766 |
| | Unusual and underappreciated: small cell carcinoma of the prostate. | Q36725653 |
| | A causal role for ERG in neoplastic transformation of prostate epithelium. | Q36883091 |
| | The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis | Q36899790 |
| | The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications | Q37460610 |
| | ETS gene fusions in prostate cancer: from discovery to daily clinical practice | Q37467056 |
| | Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer | Q38094818 |
| | EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. | Q38160994 |
| | Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis | Q38250049 |
| | Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers | Q38301071 |
| | Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells | Q38335697 |
| | Next generation biomarkers in prostate cancer. | Q38681149 |
| | Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. | Q39532714 |
| | Serial biopsy results in prostate cancer screening study | Q39601460 |
| | The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy | Q39667433 |
| | Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer | Q39787898 |
| | Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer | Q39811511 |
| | Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer | Q40038137 |
| | Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer | Q40077903 |
| | Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy | Q40086544 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| | prostate cancer | Q181257 |
| P304 | page(s) | 65-71 | |
| P577 | publication date | 2016-02-01 | |
| P1433 | published in | Chinese Journal of Cancer Research | Q26841836 |
| P1476 | title | PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer | |
| P478 | volume | 28 | |